` MNOW (Mednow Inc) vs 6618 (JD Health International Inc) Comparison - Alpha Spread

M
MNOW
vs
6618

Over the past 12 months, MNOW has underperformed JD Health International Inc, delivering a return of 0% compared to the JD Health International Inc's +38% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
MNOW
6618
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

M
MNOW Intrinsic Value
Not Available
Intrinsic Value
57.19 HKD
Undervaluation 13%
Intrinsic Value
Price HK$49.98
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
M
Mednow Inc
XTSX:MNOW
0.02 CAD
JD Health International Inc
HKEX:6618
49.98 HKD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
MNOW, 6618

MNOW
6618
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
M
Mednow Inc
Revenue
JD Health International Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
MNOW, 6618

MNOW
6618
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
M
Mednow Inc
XTSX:MNOW
JD Health International Inc
HKEX:6618
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

MNOW
11.7%
JD Health International Inc
24.8%

Operating Margin

MNOW
-60.5%
JD Health International Inc
6.4%

Net Margin

MNOW
-62.2%
JD Health International Inc
7.3%

FCF Margin

MNOW
-26.2%
JD Health International Inc
11.3%

ROE

MNOW
-297.1%
JD Health International Inc
9.3%

ROA

MNOW
-114.5%
JD Health International Inc
7%

ROIC

MNOW
-185.5%
JD Health International Inc
15.6%

ROCE

MNOW
-210.7%
JD Health International Inc
8.1%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
MNOW, 6618

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MNOW, 6618

Loading
MNOW
6618
Difference
www.alphaspread.com

Performance By Year
MNOW, 6618

Loading
MNOW
6618
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare MNOW to other stocks
CVS
CVS Health Corp
Cheaper
vs MNOW
CLS
Clicks Group Ltd
C
Cheaper
vs MNOW
WBA
Walgreens Boots Alliance Inc
Cheaper
vs MNOW
RADL3
Raia Drogasil SA
Cheaper
vs MNOW
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett